Some studies have demonstrated that AIFM2 is effective for the suppression of tumorigenicity in epithelial ovarian cancer and lung cancer cells (Notaridou et al., 2011; Lu et al., 2016). The gene discussed is AIFM2; the disease is lung carcinoma.